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A placebo is a treatment without an active ingredient often used to study the psychological
effects on the human mind and body. PURPOSE: To evaluate the effect varying doses of
placebo has on the Reserve Officer Training Corps (ROTC) Army Physical Fitness Test
(APFT). METHODS: Fourteen male and female individuals in the ages ranging from 19-21,
who are enrolled in the ROTC program at Shippensburg University, volunteered to participate in
this study. Subjects completed a standardized ROTC APFT under each condition (baseline
(CON), single dose (P1), and double dose (P2) placebo) separated by one week. On placebo
days, subjects were deceived and instructed to take a newly developed “pre-workout”
supplement 30 minutes prior to the APFT test. The APFT included push-ups and sit-ups for 2
minutes each and a 2-mile run. A Performance Perception Questionnaire (PPQ) was also
completed at the end of each day to assess the performance perception (PP) including anxiety,
energy and strength. One-way ANOVA with repeated measures was used to compare repetitions
for push-ups and sit-ups, 2-mile run time, and PP measures for three different
conditions. RESULTS: No significant changes were observed in push-ups from the CON to P1
or P2 (67.1±14.8 vs. 68.1±12.1 and 67.9±17.1 repetitions, p>0.05). A modest increase in sit-ups
scores were observed from the CON to P1 and P2 (65.7±10.0 vs. 71.3±11.0 and 67.7±13.3
repetitions, p>0.05). However, the differences were not statistically significant. Results from the
2-mile run test revealed that the run times were significantly improved at P1 when compared to
CON (14.1±1.0 vs. 15.3±1.1 min, p=0.001), but not at P2 (15.6±0.6 vs. 15.3±1.1 min, p=0.52).
When compared to CON, subjects felt significantly more anxious at P2 (1.0±1.8 vs. 0.1±2.6, p=0.04) but not at P1 (1.0±1.8 vs. 1.3±1.9, p=0.7). Similarly, perceived energy level
was significantly higher at P1 when compared to CON (3.43±1.27 vs. 0.57±2.94, p=0.01) but not
at P2 (2.00±2.45 vs. 0.57±2.94, p=0.3). Subjects felt that they had the most strength at P1
(3.7±1.6) when compared to CON (1.9±2.5) and P2 (2.0±2.5). However, these differences were
not statistically significant. CONCLUSION: While the placebo had a positive influence on
some of the performance measures as well as performance perception, P1 appeared to have the
greatest effect.

